Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	-	97.74	50.87	2.48	4.06	19.77
Cash & Short-Term Investments	-	97.74	50.87	2.48	4.06	19.77
Cash Growth	-	92.16%	1953.53%	-39.02%	-79.45%	101.70%
Accounts Receivable	-	0.03	0.23	0.06	0	0.03
Other Current Assets	0.11	0.74	0.58	1.2	0.76	0.81
Total Current Assets	0.11	98.52	51.67	3.73	4.82	20.61
Net Property, Plant & Equipment	1.02	0.99	0.45	0.61	0.99	0.58
Other Long-Term Assets	0.07	0.08	0.09	0.12	0.16	0.19
Total Assets	190.68	99.59	52.21	4.46	5.97	21.38
Accounts Payable	-	1.02	4.17	3.23	1.88	0.88
Accrued Expenses	0.48	0.43	0.48	0.47	0.4	0.28
Current Portion of Leases	0.47	0.35	0.28	0.28	0.25	0.21
Total Current Liabilities	0.95	1.8	4.92	3.98	2.53	1.37
Long-Term Leases	0.52	0.5	-	0.28	0.56	-
Other Long-Term Liabilities	-	-	0.04	-	-	-
Total Long-Term Liabilities	0.52	0.5	0.04	0.28	0.56	-
Total Liabilities	3.32	2.3	4.96	4.26	3.09	1.37
Common Stock	0	0	0	-	-	0
Additional Paid-in Capital	-	326.31	238.4	168.92	152.45	151.58
Accumulated Other Comprehensive Income	-0.88	-0.84	-0.89	-0.83	-1.25	-1.46
Retained Earnings	-	-228.18	-190.26	-167.89	-148.33	-130.12
Shareholders' Equity	187.36	97.3	47.25	0.2	2.88	20.01
Total Liabilities & Equity	190.68	99.59	52.21	4.46	5.97	21.38
Total Debt	0.99	0.85	0.28	0.56	0.81	0.21
Net Cash (Debt)	-0.99	96.9	50.58	1.92	3.25	19.56
Net Cash Growth	-	91.56%	2537.23%	-41.00%	-83.38%	108.13%
Net Cash Per Share	-0.02	2.68	2.75	1.38	6.76	77.40
Book Value	187.36	97.3	47.25	0.2	2.88	20.01
Book Value Per Share	4.48	2.69	2.57	0.15	6.00	79.19
Tangible Book Value	187.36	97.3	47.25	0.2	2.88	20.01
Tangible Book Value Per Share	4.48	2.69	2.57	0.15	6.00	79.19

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q